دورية أكاديمية
Treatment of prostatitis with low-intensity extracorporeal shockwave therapy (LI-ESWT).
| العنوان: | Treatment of prostatitis with low-intensity extracorporeal shockwave therapy (LI-ESWT). |
|---|---|
| المؤلفون: | Daneshwar D; Urology Clinic, Prince Court Medical Centre, 39, Jalan Kia Peng, 50450, Kuala Lumpur, Malaysia. datesh.daneshwar@princecourt.com., Nordin A; MedCentral Consulting, International Youth Centre, Jalan Yaacob Latiff, Bandar Tun Razak, Cheras, 56000, Kuala Lumpur, Malaysia. |
| المصدر: | International urology and nephrology [Int Urol Nephrol] 2023 Dec; Vol. 55 (12), pp. 3133-3145. Date of Electronic Publication: 2023 May 05. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Springer Country of Publication: Netherlands NLM ID: 0262521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2584 (Electronic) Linking ISSN: 03011623 NLM ISO Abbreviation: Int Urol Nephrol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Amsterdam : Springer Original Publication: Budapest, Akademiai Kiadó |
| مواضيع طبية MeSH: | Prostatitis*/therapy , Extracorporeal Shockwave Therapy*/methods, Male ; Humans ; Quality of Life ; Penile Erection |
| مستخلص: | Background: Prostatitis is known as the inflammation of the prostate. The treatments of prostatitis are either pharmacological or non-pharmacological treatment. However, some of the treatments are not effective and very invasive which can lead to side effects. Thus, low-intensity extracorporeal shockwave therapy (LI-ESWT) is used as an alternative treatment for prostatitis due to its convenient and non-invasive procedure. However, a definite protocol for this treatment is not available due to the variability of the treatment protocols and the lack of research comparing the efficacy of these protocols. Objective: To review and compare the efficacy of different LI-ESWT protocols in treating prostatitis. Methods: The study was performed by comparing the intensity, duration, frequency and combination with different types of pharmacotherapy drugs of the different LI-ESWT protocols from various studies. The finding from various studies which consist of disease improvement and quality of life (QoL) were also presented in this review. Result: From the findings, the protocol can be categorized into three different intensities which are at 3000 pulses, < 3000 pulses and > 3000 pulses. Most studies reported that each protocol is very effective and safe to use and can improve CP symptoms, urinary symptoms, erectile function and QoL. It is also found that no complications or adverse effects occur to the patient. Conclusion: Most of the LI-ESWT protocols described are safe and effective in treating CP through the absence of treatment-related adverse effects and maintenance of clinical effects. (© 2023. The Author(s), under exclusive licence to Springer Nature B.V.) |
| References: | Sugimoto M, Hijikata Y, Tohi Y, Kuroda H, Takei M, Matsuki T et al (2022) Low quality of life in men with chronic prostatitis-like symptoms. Prostate Cancer Prostatic Dis 25(4):785–790. (PMID: 10.1038/s41391-022-00559-w357526569705241) Pirola GM, Verdacchi T, Rosadi S, Annino F, De Angelis M (2019) Chronic prostatitis: current treatment options. Res Rep Urol 11:165–174. (PMID: 312402026556531) Khan FU, Ihsan AU, Khan HU, Jana R, Wazir J, Khongorzul P et al (2017) Comprehensive overview of prostatitis. Biomed Pharmacother 94:1064–1076. (PMID: 10.1016/j.biopha.2017.08.01628813783) Kim KS, Choi YS, Bae WJ, Cho HJ, Ha U-S, Hong S-H et al (2022) Efficacy of low-intensity extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome IIIb: a prospective-randomized, double-blind, placebo-controlled study. World J Mens Health 40:473. https://doi.org/10.5534/wjmh.210010. (PMID: 10.5534/wjmh.21001034448374) Zhang J, Liang CZ, Shang X, Li H (2020) Chronic prostatitis/chronic pelvic pain syndrome: a disease or symptom? Current perspectives on diagnosis, treatment, and prognosis. Am J Mens Health 14:1557988320903200. (PMID: 10.1177/1557988320903200320050887256330) Kunishima Y, Mori M, Kitamura H, Satoh H, Tsukamoto T (2006) Prevalence of prostatitis-like symptoms in Japanese men: population-based study in a town in Hokkaido. Int J Urol 13:1286–1289. (PMID: 10.1111/j.1442-2042.2004.01556.x17010006) Brede CM, Shoskes DA (2011) The etiology and management of acute prostatitis. Nat Rev Urol 8:207–212. (PMID: 10.1038/nrurol.2011.2221403661) Dunphy EJ, Eickhoff JC, Muller CH, Berger RE, McNeel DG (2004) Identification of antigen-specific IgG in sera from patients with chronic prostatitis. J Clin Immunol 24:492–502. (PMID: 10.1023/B:JOCI.0000040920.96065.5a15359108) John H, Maake C, Barghorn A, Zbinden R, Hauri D, Joller-Jemelka HI (2003) Immunological alterations in the ejaculate of chronic prostatitis patients: Clues for autoimmunity. Andrologia 35:294–299. (PMID: 10.1111/j.1439-0272.2003.tb00860.x14535858) Breser ML, Salazar FC, Rivero VE, Motrich RD (2017) Immunological mechanisms underlying chronic pelvic pain and prostate inflammation in chronic pelvic pain syndrome. Front Immunol 8:898. (PMID: 10.3389/fimmu.2017.00898288246265535188) Trishch VI, Matskevych VM, Mysak AI, Zhulkevych IV (2021) Evaluation of efficacy of extracorporeal shock wave therapy in complex treatment of patients with chronic non-bacterial prostatitis/chronic pelvic pain syndrome. Wiad Lek 74:1834–1838. (PMID: 10.36740/WLek20210811034537729) Murphy AB, Macejko A, Taylor A, Nadler RB (2009) Chronic prostatitis: management strategies. Drugs 69:71–84. (PMID: 10.2165/00003495-200969010-0000519192937) Anothaisintawee T, Attia J, Nickel JC, Thammakraisorn S, Numthavaj P, McEvoy M et al (2011) Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA - J Am Med Assoc 305:78–86. (PMID: 10.1001/jama.2010.1913) Nickel JC, Attia JR, Anothaisintawee T, Thakkinstian A (2011) MP-08.18 alpha-blockers, antibiotics and anti-inflammatories have a role in management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology 78(3):S91–S92. (PMID: 10.1016/j.urology.2011.07.195) Schneider MP, Tellenbach M, Mordasini L, Thalmann GN, Kessler TM (2013) Refractory chronic pelvic pain syndrome in men: can transcutaneous electrical nerve stimulation help? BJU Int 112:E159–E163. (PMID: 10.1111/bju.1200523433012) Birowo P, Rangganata E, Rasyid N, Atmoko W (2020) Efficacy and safety of extracorporeal shockwave therapy for the treatment of chronic non-bacterial prostatitis: a systematic review and meta-analysis. PLoS ONE 15:e0244295. https://doi.org/10.1371/journal.pone.0244295. (PMID: 10.1371/journal.pone.0244295333703727769278) Zimmermann R, Cumpanas A, Hoeltl L, Janetschek G, Stenzl A, Miclea F (2008) Extracorporeal shock-wave therapy for treating chronic pelvic pain syndrome: a feasibility study and the first clinical results. BJU Int 102:976–980. (PMID: 10.1111/j.1464-410X.2008.07742.x18510660) Le BV, Schaeffer AJ (2009) Genitourinary pain syndromes, prostatitis, and lower urinary tract symptoms. Urol Clin North Am 36:527–536. (PMID: 10.1016/j.ucl.2009.08.00519942050) Fall M, Baranowski AP, Elneil S, Engeler D, Hughes J, Messelink EJ et al (2010) EAU guidelines on chronic pelvic pain. Eur Urol 57:35–48. (PMID: 10.1016/j.eururo.2009.08.02019733958) Li G, Man L (2021) Low-intensity extracorporeal shock wave therapy for male chronic pelvic pain syndrome: a systematic review and meta-analysis. Transl Androl Urol 10:1202–1211. (PMID: 10.21037/tau-20-1423338507558039608) Li G, Man L (2020) Low-intensity extracorporeal shock wave therapy for III B chronic pelvic pain syndrome. Transl Androl Urol 9:1323–1328. (PMID: 10.21037/tau.2020.04.07326764167354340) Mohammad Al Edwan G, Muheilan MM, Mohummad Al Shudifat A, Mohammad Hawamdeh Z, Shluol JT (2016) Treatment of chronic abacterial prostatitis using extracorporeal shock wave therapy [ESWT]. Jordan Med J 50:195–202. (PMID: 10.12816/0035055) Zhang ZX, Zhang D, Yu XT, Ma YW (2019) Efficacy of radial extracorporeal shock wave therapy for chronic pelvic pain syndrome: a nonrandomized controlled trial. Am J Mens Health 13:1557988318814663. (PMID: 10.1177/155798831881466330486723) Daneshwar D, Nordin A (2022) Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome patients with erectile dysfunction. Med (United States) 101:e28546. Mykoniatis I, Pyrgidis N, Kalyvianakis D, Zilotis F, Kapoteli P, Fournaraki A et al (2021) Comparing two different low-intensity shockwave therapy frequency protocols for nonbacterial chronic prostatitis/chronic pelvic pain syndrome: a two-arm, parallel-group randomized controlled trial. Prostate 81:499–507. (PMID: 10.1002/pros.2411933929052) Zimmermann R, Cumpanas A, Miclea F, Janetschek G (2009) Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study. Eur Urol 56:418–424. (PMID: 10.1016/j.eururo.2009.03.04319372000) Skaudickas D, Telksnys T, Veikutis V, Aniulis P, Jievaltas M (2020) Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome. Open Med Gruyter Open Ltd 15:580–585. (PMID: 10.1515/med-2020-0174) Jin C, Zhang S, Mo F, Zhang M, Meng J, Bian Z et al (2022) Efficacy and safety evaluation of low-intensity extracorporeal shock wave therapy on prostatitis-like symptoms: an open-label, single-arm trial. Andrologia 54:e14260. (PMID: 10.1111/and.1426034585431) Sakr AM, Fawzi AM, Kamel M, Ali MM (2022) Outcomes and clinical predictors of extracorporeal shock wave therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome: a prospective randomized double-blind placebo-controlled clinical trial. Prostate Cancer Prostatic Dis 25:93–99. (PMID: 10.1038/s41391-021-00464-834635804) Guu SJ, Geng JH, Chao IT, Lin HT, Lee YC, Juan YS et al (2018) Efficacy of low-intensity extracorporeal shock wave therapy on men with chronic pelvic pain syndrome refractory to 3-As therapy. Am J Mens Health 12:441–452. (PMID: 10.1177/155798831773658529072124) Vahdatpour B, Alizadeh F, Moayednia A, Emadi M, Khorami MH, Haghdani S (2013) Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized. Control Trial ISRN Urol 2013:972601. Moayednia A, Haghdani S, Khosrawi S, Yousefi E, Vahdatpour B (2014) Long-term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. J Res Med Sci 19:293–296. (PMID: 250975994115342) Pajovic B, Radojevic N, Dimitrovski A, Vukovic M (2016) Comparison of the efficiency of combined extracorporeal shock-wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male 19:202–207. (PMID: 10.1080/13685538.2016.119789927380504) Wu WL, Bamodu OA, Wang YH, Hu SW, Tzou KY, Yeh CT et al (2021) Extracorporeal shockwave therapy (ESWT) alleviates pain, enhances erectile function and improves quality of life in patients with chronic prostatitis/chronic pelvic pain syndrome. J Clin Med 10:3602. (PMID: 10.3390/jcm10163602344419028396816) Salama AB, Abouelnaga WA (2018) Effect of radial shock wave on chronic pelvic pain syndrome/chronic prostatitis. J Phys Ther Sci 30:1145–1149. (PMID: 10.1589/jpts.30.1145302141146127492) Al Edwan GM, Muheilan MM, Atta ONM (2017) Long term efficacy of extracorporeal shock wave therapy [ESWT] for treatment of refractory chronic abacterial prostatitis. Ann Med Surg 14:12–17. (PMID: 10.1016/j.amsu.2016.12.051) Zeng XY, Liang C, Ye ZQ (2012) Extracorporeal shock wave treatment for non-inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham-controlled study. Chin Med J (Engl) 125:114–118. (PMID: 22340476) Mykoniatis I, Kalyvianakis D, Zilotis F, Kapoteli P, Fournaraki A, Poulios E et al (2021) Evaluation of a low-intensity shockwave therapy for chronic prostatitis type IIIb/chronic pelvic pain syndrome: a double-blind randomized sham-controlled clinical trial. Prostate Cancer Prostatic Dis 24:370–379. (PMID: 10.1038/s41391-020-00284-232989261) |
| فهرسة مساهمة: | Keywords: LI-ESWT; Prostatitis; Quality of life (QoL); Review; Treatment |
| تواريخ الأحداث: | Date Created: 20230505 Date Completed: 20231030 Latest Revision: 20231030 |
| رمز التحديث: | 20231030 |
| DOI: | 10.1007/s11255-023-03616-y |
| PMID: | 37145375 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder كن أول من يترك تعليقا!